Antidiabetic Effects of a Standardized Egyptian Rice Bran Extract
Antidiabetic Effects of a Standardized Egyptian Rice Bran Extract
复制标题
DOI:
10.1002/ptr.4705
复制
发表时间:
2013-02-01
影响因子:
7.2
通讯作者:
Verspohl, Eugen J.
中科院分区:
文献类型:
--
作者:
Kaup, Rebecca M.;Khayyal, Mohamed T.;Verspohl, Eugen J.
An extract was prepared from Egyptian stabilized rice bran and standardized to contain 2% -oryzanol in addition to its content of other bioactives, notably tocotrienol and policosanol. The standardized extract was found to have a concentration-dependent effect on insulin release in vitro, which, however, is not mediated by -tocotrienol in rice bran (detected by HPLC) as could have been expected. Policosanol and -oryzanol have insulinotropic effects. The in vitro data of rice bran directly translate into in vivo data of rats by using a glucose tolerance test (increase in plasma insulin). Tocotrienols are well known for their apoptotic effect on tumor cells; nevertheless, an attempt was made to study glucose uptake in HEP-G2 cells, which needs to induce an insulin-resistant state by TNF-. The Egyptian rice bran extract has an antidiabetic effect. -Oryzanol, which is a possible precursor of the insulinotropic compound ferulic acid, is a candidate for this effect. Therefore, it is reasonable to assume that the prevalence of diabetes or at least a prediabetic (type 2) situation can be ameliorated by the investigated rice bran extract. The potential usefulness of the extract as a nutraceutical is currently undergoing more thorough investigations. Copyright (c) 2012 John Wiley & Sons, Ltd.